Cancer genetics and precision medicine
Rob Pieters, Chief Medical Officer (CMO) at Princess Máxima Center for Pediatric Oncology and Professor of Pediatric Oncology at the University of Utrecht (The Netherlands) Precision Medicine in the Princess Máxima Center for Pediatric Oncology
David Gisselsson Nord, Division of Clinical Genetics; Principal investigator at LUCC: Lund University Cancer Centre (Sweden) Implementing nationwide whole genome sequencing for all children with cancer in Sweden
Alwin Krämer, Full Professor at the University of Heidelberg, Director of the Clinical Cooperation Unit Molecular Hematology/Oncology of German Cancer Research Center (DKFZ), Department of Internal Medicine, University of Heidelberg (Germany) Precision oncology approaches in cancer of unknown primary (CUP)
Martin Zoche, director at Molecular Tumor Profiling, Dept. of Pathology and Molecular Pathology, University Hospital Zurich and a Lecturer at the University of Zurich (Switzerland) Homologous Recombination Deficiency (HRD) Testing in Clinical Practice
Juha Kononen, Chief Clinical Director, Docrates Cancer Clinic (Finland) Precision oncology in clinical practice: successes and challenges
Jukka Kanerva, Consultant in pediatric hematology and oncology, New Children’s Hospital, Helsinki University Hospital and University of Helsinki (Finland) Pediatric precision medicine at Helsinki University Hospital
PMNET Forum 2022
-
Category
No comments found